
Neurology Drugs & Nervous System Drugs
Prescription drugs and medicines for conditions concerning the nervous system; especially the brain, peripheral nerves, and spinal cord. Studies in this field include: Alzheimer’s Disease, Attention Deficit Hyperactivity Disorder (ADHD), Carpal Tunnel Syndrome, Huntington’s Disease, dementia, memory loss, migraine headaches, multiple sclerosis, muscular dystrophy, Parkinson’s Disease, strokes, Tourette’s Syndrome, and others.
The list of FDA approved drugs for neurology and the nervous system appears below. Click any link to view the full drug information.
Number Of Neurology Drugs & Nervous System Drugs: 132
For the treatment of breakthrough cancer pain in opioid-tolerant patients
Aggrenox (aspirin/extended-release dipyridamole) 25mg/200mg capules for the prevention of recurrence of stroke
Treatment for acute migraine
For the improvement of walking in patients with multiple sclerosis
For the treatment of muscle spasm associated with acute, painful musculoskeletal conditions
Treatment for chronic pain
For the treatment of acute, intermittent hypomobility episodes associated with advanced Parkinson?s disease
Treatment for Alzheimer's Disease
Extended release capsule for the relief of pain requiring continuous, around-the-clock therapy
Treatment for multiple sclerosis
For the treatment of migraine attacks
For the treatment of Alzheimer's disease
For the treatment of seizures associated with Lennox-Gastaut syndrome in pediatrics and adults
Oral treatment for mild to moderate migraine pain
For the treatment of upper limb spasticity
For the treatment of chronic migraine
Management of acute pain
moderate to severe chronic pain
For the treatment of migraine attacks
For the treatment of hyperammonemia
Treatment for epileptic seizures and trigeminal neuralgia
Treatment for symptoms associated with menopause
Oral agent for the treatment for erectile dysfunction
Generic equivalent of Klonopin
200mg entacapone tablets
Treatment for relapsing-remitting multiple sclerosis
For the treatment of chronic severe drooling in pediatrics with neurologic conditions
Treatment for Attention Deficit Disorder
Treatment for migraine headaches
Treatment for epilepsy
For the prophylaxis (prevention) of migraine headaches in adults
For the treatment of inflammation and pain associated with ocular surgery
For the treatment of insomnia
For the treatment of moderate to severe pain
For the management of moderate to severe pain
Treatment for mild to moderate migraine pain
Indicated for the treatment of mild to moderate dementia of the Alzheimer's type
For the treatment of Alzheimer's and Parkinson's disease-related dementia
For postsurgical analgesia
For the treatment of relapsing multiple sclerosis
For the treatment of attention deficit hyperactivity disorder (ADHD)
Tablets for the acute treatment of migraine attacks
Treatment for Wilson?s disease
For the treatment of postherpetic neuralgia
For the treatment of postherpetic neuralgia
For the treatment of restless legs syndrome
Treatment for migraine headaches
Treatment for migraine
For the treatment of insomnia
For the treatment of ADHD in children and adolescents
For the treatment of schizophrenia
Needle-free anesthetic
Treatment for chronic moderate to severe pain
For the treatment of attention deficit hyperactivity disorder
Levetiracetam tablets for adjunctive treatment of partial onset seizures in adults with epilepsy
Treatment for epileptic seizures
Treatment for Epilepsy
For the management of breakthrough cancer pain
For the treatment of erectile dysfunction related to sexual activity in men
Treatment of pain in post-herpetic neuralgia
For the treatment of insomnia and sleep maintenance
A sedative-hypnotic agent indicated for monitored anesthesia care sedation
For the treatment of pain associated with diabetic peripheral neuropathy and postherpetic neuralgia
For the treatment of neuropathic pain associated with spinal cord injury
Acute treatment of migraine headache
Treatment for intra-abdominal infections and bacterial meningitis
Oral capsules for the treatment of attention deficit hyperactivity disorder
Treatment for migraine headaches
Treatment for Parkinson?s Disease
Injectable solution for the treatment of abnormal head position and neck pain associated with cervical dystonia
Generic equivalent of Revia
For the treatment of moderate to severe dementia of the Alzheimer?s type.
For the treatment of Restless Legs Syndrome
For the treatment of Parkinson's disease
Oral treatment for the management of post-herpetic neuralgia (PHN)
Treatment of partial seizures in adults with epilepsy
For the treatment of partial seizures in pediatric patients three years of age and older
Treatment for moderate to moderately severe pain
For reducing neurologic disability and/or the frequency of clinical relapses in patients with multiple sclerosis
moderate to severe acute pain
For the treatment of pseudobulbar affect
For the treatment of excessive sleepiness
For the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome
For the management of breakthrough cancer pain
For the management of acute and chronic moderate to severe pain
Generic equivalent of Percodan
Generic equivalent of Percocet and Tylox
For the treatment of partial-onset seizures
Treatment for Parkinson's Disease
Treatment for pain associated with bone cancer
For the treatment of Attention Deficit Hyperactivity Disorder
For the treatment of neuropathic pain associated with postherpetic neuralgia
Subcutaneous injection for the treatment of relapsing forms of multiple sclerosis
Treatment for obesity
For the acute treatment of migraine headaches
For the treatment of mild to moderate dementia of the Alzheimer's type
Treatment for Parkinson's Disease
Treatment for amyotrophic lateral sclerosis (ALS)
For the treatment of sleep-onset insomnia
For the treatment of infantile spasms and complex partial seizures
Generic equivalent of Eldepryl tablets
For the treatment of insomnia
Treatment fo insomnia
For the treatment of moderate to severe pain
For the treatment of bipolar manic disorder, seizures and migraine headaches
For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents and adults.
For the treatment of breakthrough cancer pain
Treatment for Parkinson's Disease
Treatment for young children with epilepsy
Anti-epileptic treatment
Treatment for partial onset seizures
Treatment for epilepsy in pediatric patients
Approved for use as adjunctive therapy in the treatment of partial seizures in children (monotherapy for adults)
For the treatment of relapsing forms of multiple sclerosis
For the short-term management of acute pain
Treatment for chronic pain
Treatment for sedating children who must undergo painful surgery
For the treatment of major depressive disorder
For the treatment of partial-onset seizures in adults with epilepsy
Diagnostic contrast agent
For the treatment of alcohol dependence
For the prevention of relapse to opioid dependence
For the treatment of type 1 Gaucher disease
For the treatment of Attention-Deficit/Hyperactivity Disorder
For the treatment of chorea due to Huntington's disease
For the treatment of hepatic encephalopathy
For the treatment of cataplexy, a sudden loss of muscle tone, associated with narcolepsy
Treatment for muscle spasticity
For the treatment of mild to moderate acute pain
Orally disintegrating tablet for the treatment of acute migraine in adults
Treatment for migraine
Adjunctive therapy for treatment of partial seizures in adults with epilepsy
FDA Approved Neurology Drugs & Nervous System Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA neurology drugs & nervous system drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The neurology drugs & nervous system drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



